| 1 |
Motiei M, Lucia LA, Sáha T, Sáha P. Current state-of-the-art review of nanotechnology-based therapeutics for viral pandemics: Special attention to COVID-19. Nanotechnology Reviews 2023;12. [DOI: 10.1515/ntrev-2022-0515] [Reference Citation Analysis]
|
| 2 |
Deshayes C, Gosselin-Grenet AS, Ogliastro M, Lapied B, Apaire-Marchais V. Can Virus-like Particles Be Used as Synergistic Agent in Pest Management? Viruses 2022;14:943. [PMID: 35632685 DOI: 10.3390/v14050943] [Reference Citation Analysis]
|
| 3 |
Yato K, Matsuda M, Watanabe N, Watashi K, Aizaki H, Kato T, Tamura K, Wakita T, Muramatsu M, Suzuki R. Induction of neutralizing antibodies against hepatitis C virus by a subviral particle-based DNA vaccine. Antiviral Research 2022. [DOI: 10.1016/j.antiviral.2022.105266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Du L, Yang Y, Zhang X, Li F. Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies. Nanoscale 2022;14:1054-74. [PMID: 35018939 DOI: 10.1039/d1nr03831a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 5 |
Lebeau G, Lagrave A, Ogire E, Grondin L, Seriacaroupin S, Moutoussamy C, Mavingui P, Hoarau JJ, Roche M, Krejbich-Trotot P, Desprès P, Viranaicken W. Viral Toxin NS1 Implication in Dengue Pathogenesis Making It a Pivotal Target in Development of Efficient Vaccine. Vaccines (Basel) 2021;9:946. [PMID: 34579183 DOI: 10.3390/vaccines9090946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Cimica V, Galarza JM, Rashid S, Stedman TT. Current development of Zika virus vaccines with special emphasis on virus-like particle technology. Expert Rev Vaccines 2021;:1-16. [PMID: 34148481 DOI: 10.1080/14760584.2021.1945447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Choi JA, Wu K, Kim GN, Saeedian N, Seon SH, Park G, Jung DI, Jeong HW, Kim NH, Seo SH, Lee S, Song M, Kang CY. Induction of protective immune responses against a lethal Zika virus challenge post-vaccination with a dual serotype of recombinant vesicular stomatitis virus carrying the genetically modified Zika virus E protein gene. J Gen Virol 2021;102. [PMID: 33913804 DOI: 10.1099/jgv.0.001588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Cimica V, Saleem S, Matuczinski E, Adams-Fish D, McMahon C, Rashid S, Stedman TT. A Virus-Like Particle-Based Vaccine Candidate against the Tick-Borne Powassan Virus Induces Neutralizing Antibodies in a Mouse Model. Pathogens 2021;10:680. [PMID: 34072726 DOI: 10.3390/pathogens10060680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Temchura V. Decorated and Encapsulated: Virus-Like Particles Against Viral Infections. Vaccines (Basel) 2021;9:273. [PMID: 33803636 DOI: 10.3390/vaccines9030273] [Reference Citation Analysis]
|
